Exhibit 99.1
SECURITIES AND EXCHANGE COMMISSION | ||
Washington, D.C. 20549 | ||
FORM 8-K | ||
CURRENT REPORT | ||
Pursuant to Section 13 or 15(d) of the | ||
Securities Exchange Act of 1934 | ||
Date of Report (Date of earliest event reported): June 4, 2013 (June 4, 2013) | ||
National Health Investors, Inc. | ||
(Exact name of Registrant as specified in its charter) | ||
Maryland | 001-10822 | 62-1470956 |
(State or Other Jurisdiction of Incorporation) | (Commission File No.) | (IRS Employer Identification Number) |
222 Robert Rose Drive Murfreesboro, TN 37129 | ||
(Address of principal executive offices) | ||
(615) 890-9100 | ||
(Registrant's telephone number, including area code) | ||
Not Applicable | ||
(Former name or former address, if changed since last report) | ||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): | ||
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c) | ||
Exhibit No: | Description |
99.1 | HTML Version of Jefferies Handout to be used in June 5, 2013 Presentation |
99.2 | HTML Version of updated June Investor Handout |
